| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 02/06/2008 | CN101117637A Strict hypoxia targeting carrier and uses thereof |
| 02/06/2008 | CN101116750A Canine adenovirus DNA vaccines pVAX1-CpG-Loop |
| 02/06/2008 | CN101116749A Swine fever replicon carrier vaccines, the method for preparing the same and application thereof |
| 02/06/2008 | CN101116748A Adriablastina antineoplastic medicine and gland correlated virus composite preparations and uses thereof |
| 02/06/2008 | CN101116747A Cytosine arabinoside and gland correlated virus composite preparations and uses thereof |
| 02/06/2008 | CN100366735C Sebocytes, sebocyte cell lines and applications thereof |
| 02/06/2008 | CN100366257C Stromal cell-derived factor-1 mediates stem cell homing and tissue regeneration in ischemic cardiomyopathy |
| 02/05/2008 | US7326778 Mutator gene and hereditary non-polyposis colorectal cancer |
| 02/05/2008 | US7326767 Immunotherapeutic methods using epitopes of WT-1 and GATA-1 |
| 02/05/2008 | US7326693 Antisense modulation of c-reactive protein expression |
| 02/05/2008 | US7326692 Induction of immunity using inhibitors of granzymes |
| 02/05/2008 | US7326572 Culturing in a medium including Activin A to cause differentiation into endoderm cells that express the markers Sox 17, HNF313 and HNF4a; pancreatic islet cells |
| 02/05/2008 | US7326545 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 02/05/2008 | US7326537 In human blood, urine, saliva, tissue biopsy or autopsy material; immunoassay using a mono- or polyclonal antibody; detecting overexpression; diagnosis |
| 02/05/2008 | US7326418 Identification of novel factors that block programmed cell death or apoptosis by targeting JNK |
| 02/05/2008 | CA2187161C Dna encoding precursor of interleukin-1.beta. converting enzyme-related cysteine proteinase ii (icerel-ii) |
| 01/31/2008 | WO2008014404A2 Receptor-mediated delivery : compositions and methods |
| 01/31/2008 | WO2008014008A2 Compositions and methods for modulating angiogenesis |
| 01/31/2008 | WO2008013928A2 Treatment of cancer with interferon gene delivery in combination with a tgf-beta inhibitor |
| 01/31/2008 | WO2008013863A2 Generation of adipose tissue and adipocytes |
| 01/31/2008 | WO2008013782A2 Methods for promoting myelination, neuronal survival and oligodendrocyte differentiation via administration of sp35 or trka antagonists |
| 01/31/2008 | WO2008013737A2 Compositions for reprogramming a cell and uses therefor |
| 01/31/2008 | WO2008013473A1 Disease treating method |
| 01/31/2008 | WO2008013324A1 Use of diabetes-related, liver-derived secreted protein in diagnosis or treatment of type-2 diabetes or vascular disorder |
| 01/31/2008 | WO2008013067A1 Human artificial chromosome (hac) vector, and human cell pharmaceutical comprising human artificial chromosome (hac) vector |
| 01/31/2008 | WO2008012682A2 Methods and compositions for increasing tissue tropism of recombinant adenoviral vectors |
| 01/31/2008 | WO2008012576A2 Assay for diagnosing a predisposition to pathological bone conditions and anticipating response to treatment |
| 01/31/2008 | WO2008011709A1 Biomarkers for use in the diagnosis and treatment of colorectal cancer |
| 01/31/2008 | WO2007047256A3 Svv-based animal vaccines and uses thereof |
| 01/31/2008 | US20080027018 Electrotransfer of nucleic acid into tissue cells |
| 01/31/2008 | US20080027017 Spinal and nerve application of genomic replacement therapy |
| 01/31/2008 | US20080027016 Cancer treatment application of genomic replacement therapy |
| 01/31/2008 | US20080027005 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/31/2008 | US20080026985 Control of gene expression |
| 01/31/2008 | US20080026399 treating bladder and lower urinary tract syndromes particularly irrative symptoms using alpha 1d-adrenergic receptor ( alpha 1dAR) antagonists; drug screening |
| 01/31/2008 | US20080026377 Skin wrinkle application of genomic replacement therapy |
| 01/31/2008 | US20080026071 Microparticles for delivery of heterologous nucleic acids |
| 01/31/2008 | US20080026048 Reovirus for the treatment of cellular proliferative disorders |
| 01/31/2008 | US20080026012 Recombinant cancer cell secreting modified heat shock protein-antigenic peptide complex |
| 01/31/2008 | US20080026011 Immunostimulatory nucleic acid molecules |
| 01/31/2008 | US20080025997 Cysteine-rich region of respiratory syncytial virus and methods of use therefor |
| 01/31/2008 | US20080025967 Method and Kit for Detecting Proliferative Diseases Causing Sclerosis, Preventive and/or Remedy for Proliferative Diseases Causing Sclerosis and Method and Kit for Identifying Substance Efficacious in Preventing and/or Treating Proliferative Diseases Causing Sclerosis |
| 01/31/2008 | US20080025958 Bar coded library; detecting gene sensitive to tumors; transfection of stem cells; anticancer agents |
| 01/31/2008 | US20080025957 Stem Cells Suitable for Transplantation, their Preparation and Pharmaceutical Compositions Comprising Them |
| 01/31/2008 | US20080025952 Methods for targeted deliver of genetic material to the liver |
| 01/31/2008 | US20080025951 Administering to an individual having acute liver disease or inflammatory skin disease a carrier and a specific polypeptide that contains signal peptide sequences and a transmembrane spanning domain |
| 01/31/2008 | CA2658204A1 Human artificial chromosome (hac) vector and human cell medicine comprising same |
| 01/30/2008 | EP1468110A4 Molecular signatures of commonly fatal carcinomas |
| 01/30/2008 | EP1163254B1 Trpm-2 antisense therapy |
| 01/30/2008 | EP0972063B1 Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof |
| 01/30/2008 | EP0941125B1 Methods for regulating angiogenesis |
| 01/30/2008 | CN101115494A Method of modulating vascularization |
| 01/30/2008 | CN101113478A Method for diagnosing testicular seminomas |
| 01/30/2008 | CN101113459A Recombination duplicating deficient virus, pharmaceutical composition containing the virus and uses thereof |
| 01/30/2008 | CN101113450A Neurotrophic factor |
| 01/30/2008 | CN101113447A Antineoplastic small molecule interfering RNA and its anti-tumor use |
| 01/30/2008 | CN101113446A siRNA for suppressing VEGF expression and breeding of tumour and leukemia cell and application thereof |
| 01/30/2008 | CN101113445A siRNA for suppressing VEGF expression and breeding of tumour and leukemia cell and application thereof |
| 01/30/2008 | CN101113444A siRNA for suppressing VEGF expression and breeding of tumour and leukemia cell and application thereof |
| 01/30/2008 | CN101113443A siRNA for suppressing VEGF expression and breeding of tumour and leukemia cell and application thereof |
| 01/30/2008 | CN101113442A siRNA for suppressing VEGF expression and breeding of tumour and leukemia cell and application thereof |
| 01/30/2008 | CN101113441A siRNA for suppressing VEGF expression and breeding of tumour and leukemia cell and application thereof |
| 01/30/2008 | CN101113440A siRNA for suppressing VEGF expression and breeding of tumour and leukemia cell and application thereof |
| 01/30/2008 | CN101113439A siRNA for suppressing VEGF expression and breeding of tumour and leukemia cell and application thereof |
| 01/30/2008 | CN101113438A Antisense STAT3 oligonucleotide and uses thereof |
| 01/30/2008 | CN101113170A Preparation of new gene cell cycle related tumour high-expression gene monoclonal antibody and its application |
| 01/30/2008 | CN101113159A Structure and usage of antisense oligonucleotide for preventing and treating lung carcinoma cell invasion transition |
| 01/30/2008 | CN101113158A siRNA disturbing RdRp gene function of SARS virus |
| 01/30/2008 | CN101112621A PRRSV and PCV-2bivalent recombinant fowl pox virus disease live vector vaccines |
| 01/30/2008 | CN100365127C Polynucleotide comprising ubiquitous chromatin opening element (UCDE) |
| 01/30/2008 | CN100365123C SiRNA sequence directing towards influenza B virus membrane protein gene and its application |
| 01/30/2008 | CN100365122C SiRNA sequence directing towards influenza B virus polymerase gene and its application |
| 01/30/2008 | CN100365121C SiRNA sequence directing towards influenza B virus nucleocapsid gene and its application |
| 01/30/2008 | CN100365120C Compounds and methods for treatment and diagnosis of chlamydial infection |
| 01/30/2008 | CN100365119C Polypeptide of anti HIV virus and its coding gene and application |
| 01/30/2008 | CN100365015C 12-mer peptide, compound containing the same, its preparation method and application in cancer treatment drug |
| 01/30/2008 | CN100365009C Anti HBV infection and hepatitis B-preventing nucleotide sequence and its use |
| 01/29/2008 | US7323619 Generation of genetically engineered animals; for use as models in the evaluation of disease |
| 01/29/2008 | US7323541 Polypeptide DNA thereof and use of the same |
| 01/29/2008 | US7323450 Combination of plasmids producing Th1 cytokines that activate NK cells and Th2 cytokines that antagonize TGF- beta inhibiting NK cells to disable immune system inhibition; canine transmissible venereal tumor |
| 01/29/2008 | US7323439 Methods and compositions for modulating angiogenesis |
| 01/29/2008 | US7323337 Gene transfer into primate embryonic stem cells using VSV-G pseudotyped simian immunodeficiency virus vectors |
| 01/29/2008 | US7323330 Genome sequences and nucleotide sequences coding for the PWD circovirus polypeptides, such as the circovirus structural and non-structural polypeptides, vectors including the sequences, and cells transformed by the vectors; kits for diagnosing infection and vaccines |
| 01/29/2008 | US7323181 Compositions and methods for WT1 specific immunotherapy |
| 01/29/2008 | US7323173 Administration of phosphorylated Mammastatin having a molecular weight of 53 kDa or 49 kDa; the polypeptide is specifically reactive with monoclonal antibody 7G6 that is produced from hybridoma ATCC No. HB10152 |
| 01/29/2008 | US7323165 Production of pancreatic islet cells and delivery of insulin |
| 01/29/2008 | CA2267651C Method of stimulating growth of melanocyte precursor cells with stem cell factor polypeptide |
| 01/29/2008 | CA2149776C Use of methioninase as an antitumor agent in anti-methionine chemotherapy |
| 01/24/2008 | WO2008011561A2 End-modified poly(beta-amino esters) and uses thereof |
| 01/24/2008 | WO2008011503A2 Use of a phage displaying a peptide from an adhesion protein for treating a disease associated with intracellular formation of protein fibrillar inclusions or aggregates |
| 01/24/2008 | WO2008011473A2 Compositions and their uses directed to hbxip |
| 01/24/2008 | WO2008011381A2 Treatment of pain through expression of opioid receptors |
| 01/24/2008 | WO2008010991A2 Methods and compositions for the treatment of cancer |
| 01/24/2008 | WO2008010811A1 Methods and compositions for inducing protective responses to antigenic toxins |
| 01/24/2008 | WO2008010637A1 Composition for attenuating neuropathic pain comprising a recombinant vector expressing gad65 |
| 01/24/2008 | WO2008010162A2 Intracellular targeting of molecules |
| 01/24/2008 | WO2008010009A1 Meganuclease variants cleaving a dna target sequence from a rag gene and uses thereof |
| 01/24/2008 | WO2008009214A1 Polypeptide, nucleic acid molecule encoding it and their uses |
| 01/24/2008 | WO2007100684A3 Extracellular matrix/metastasis modifer genes for the prevention or inhibition of metastasis or growth of tumor and for characterization of tumor |
| 01/24/2008 | WO2007093918A3 Meganuclease variants cleaving a dna target sequence from a xeroderma pigmentosum gene and uses thereof |